| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 113 | 2025 | 410 | 14.060 |
Why?
|
| Puerto Rico | 164 | 2025 | 1376 | 6.420 |
Why?
|
| Mental Disorders | 42 | 2022 | 377 | 5.410 |
Why?
|
| Child | 181 | 2025 | 3381 | 4.920 |
Why?
|
| Adolescent | 199 | 2025 | 5950 | 4.670 |
Why?
|
| Anti-Asthmatic Agents | 13 | 2025 | 45 | 2.630 |
Why?
|
| Alcohol-Related Disorders | 6 | 2019 | 63 | 2.510 |
Why?
|
| Male | 184 | 2025 | 22779 | 2.440 |
Why?
|
| Alcohol Drinking | 11 | 2023 | 585 | 2.440 |
Why?
|
| Female | 188 | 2025 | 24018 | 2.410 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 22 | 2019 | 116 | 2.350 |
Why?
|
| Humans | 247 | 2025 | 42163 | 2.300 |
Why?
|
| Depression | 14 | 2020 | 837 | 2.200 |
Why?
|
| Substance-Related Disorders | 18 | 2024 | 825 | 2.170 |
Why?
|
| Parents | 19 | 2023 | 359 | 2.140 |
Why?
|
| Child, Preschool | 61 | 2024 | 1516 | 2.110 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 14 | 2020 | 297 | 2.100 |
Why?
|
| Depressive Disorder, Major | 12 | 2024 | 128 | 2.100 |
Why?
|
| Stress, Psychological | 18 | 2024 | 641 | 1.850 |
Why?
|
| Prevalence | 46 | 2023 | 1597 | 1.840 |
Why?
|
| Child Abuse | 12 | 2024 | 90 | 1.760 |
Why?
|
| Young Adult | 59 | 2025 | 4936 | 1.730 |
Why?
|
| Mental Health Services | 14 | 2022 | 134 | 1.720 |
Why?
|
| Longitudinal Studies | 37 | 2024 | 1020 | 1.660 |
Why?
|
| Disasters | 5 | 2023 | 74 | 1.650 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 8 | 2020 | 55 | 1.620 |
Why?
|
| Culture | 13 | 2017 | 172 | 1.460 |
Why?
|
| Family Health | 3 | 2017 | 56 | 1.430 |
Why?
|
| Adult | 78 | 2024 | 13458 | 1.420 |
Why?
|
| Alcoholism | 5 | 2019 | 292 | 1.410 |
Why?
|
| Antisocial Personality Disorder | 8 | 2021 | 20 | 1.400 |
Why?
|
| Social Support | 7 | 2019 | 438 | 1.370 |
Why?
|
| Cyclonic Storms | 5 | 2022 | 75 | 1.370 |
Why?
|
| Residence Characteristics | 9 | 2024 | 359 | 1.310 |
Why?
|
| New York City | 30 | 2024 | 283 | 1.270 |
Why?
|
| Sex Factors | 20 | 2021 | 1008 | 1.220 |
Why?
|
| Parent-Child Relations | 8 | 2023 | 125 | 1.200 |
Why?
|
| Cross-Cultural Comparison | 16 | 2016 | 109 | 1.170 |
Why?
|
| Anxiety Disorders | 13 | 2017 | 319 | 1.170 |
Why?
|
| Nasal Mucosa | 7 | 2025 | 31 | 1.150 |
Why?
|
| Genome-Wide Association Study | 18 | 2022 | 421 | 1.150 |
Why?
|
| Adolescent Behavior | 10 | 2019 | 270 | 1.100 |
Why?
|
| School Health Services | 2 | 2025 | 89 | 1.090 |
Why?
|
| Rhode Island | 13 | 2023 | 17 | 1.080 |
Why?
|
| Social Environment | 12 | 2019 | 218 | 1.060 |
Why?
|
| Family | 5 | 2020 | 192 | 0.960 |
Why?
|
| Hypersensitivity | 7 | 2020 | 32 | 0.960 |
Why?
|
| Poverty | 10 | 2024 | 395 | 0.950 |
Why?
|
| Allergens | 9 | 2024 | 64 | 0.920 |
Why?
|
| Socioeconomic Factors | 18 | 2018 | 1221 | 0.920 |
Why?
|
| Violence | 10 | 2023 | 133 | 0.920 |
Why?
|
| Life Change Events | 5 | 2022 | 107 | 0.910 |
Why?
|
| Acculturation | 10 | 2019 | 203 | 0.890 |
Why?
|
| Urban Population | 7 | 2025 | 364 | 0.880 |
Why?
|
| Stress Disorders, Post-Traumatic | 5 | 2023 | 547 | 0.880 |
Why?
|
| Health Knowledge, Attitudes, Practice | 9 | 2016 | 959 | 0.870 |
Why?
|
| Anxiety | 9 | 2019 | 847 | 0.870 |
Why?
|
| Mental Health | 11 | 2024 | 363 | 0.840 |
Why?
|
| Middle Aged | 38 | 2021 | 11819 | 0.840 |
Why?
|
| Risk Factors | 38 | 2022 | 3942 | 0.800 |
Why?
|
| Health Services Accessibility | 6 | 2014 | 680 | 0.800 |
Why?
|
| Psychiatric Status Rating Scales | 11 | 2014 | 280 | 0.800 |
Why?
|
| Child of Impaired Parents | 5 | 2023 | 20 | 0.790 |
Why?
|
| Suicide, Attempted | 6 | 2021 | 104 | 0.790 |
Why?
|
| Logistic Models | 20 | 2019 | 1001 | 0.770 |
Why?
|
| Health Surveys | 11 | 2012 | 401 | 0.760 |
Why?
|
| Immunoglobulin E | 14 | 2025 | 59 | 0.760 |
Why?
|
| Depressive Disorder | 8 | 2017 | 185 | 0.740 |
Why?
|
| DNA Methylation | 11 | 2023 | 393 | 0.740 |
Why?
|
| Psychometrics | 11 | 2013 | 350 | 0.720 |
Why?
|
| Child Behavior Disorders | 3 | 2011 | 35 | 0.720 |
Why?
|
| United States | 34 | 2023 | 5072 | 0.710 |
Why?
|
| Comorbidity | 18 | 2019 | 725 | 0.710 |
Why?
|
| Healthcare Disparities | 3 | 2012 | 573 | 0.690 |
Why?
|
| Cross-Sectional Studies | 24 | 2025 | 3077 | 0.670 |
Why?
|
| Polymorphism, Single Nucleotide | 14 | 2022 | 860 | 0.670 |
Why?
|
| Conduct Disorder | 5 | 2017 | 54 | 0.670 |
Why?
|
| Parenting | 6 | 2023 | 135 | 0.640 |
Why?
|
| Health Education | 2 | 2016 | 358 | 0.630 |
Why?
|
| Family Relations | 2 | 2018 | 46 | 0.630 |
Why?
|
| Quality of Life | 8 | 2022 | 599 | 0.610 |
Why?
|
| Prospective Studies | 18 | 2024 | 1574 | 0.610 |
Why?
|
| Twins | 3 | 2015 | 18 | 0.610 |
Why?
|
| Juvenile Delinquency | 3 | 2019 | 44 | 0.600 |
Why?
|
| Primary Health Care | 4 | 2016 | 362 | 0.590 |
Why?
|
| Case-Control Studies | 20 | 2025 | 1266 | 0.590 |
Why?
|
| Child Health Services | 3 | 2011 | 42 | 0.580 |
Why?
|
| Peer Group | 2 | 2025 | 173 | 0.570 |
Why?
|
| Severity of Illness Index | 16 | 2018 | 708 | 0.570 |
Why?
|
| Protestantism | 1 | 2018 | 5 | 0.570 |
Why?
|
| Sex Offenses | 2 | 2022 | 43 | 0.560 |
Why?
|
| Environmental Exposure | 6 | 2025 | 247 | 0.550 |
Why?
|
| Vitamin D Deficiency | 5 | 2018 | 107 | 0.550 |
Why?
|
| Adrenal Cortex Hormones | 6 | 2024 | 62 | 0.550 |
Why?
|
| Somatoform Disorders | 2 | 2009 | 17 | 0.530 |
Why?
|
| Students | 1 | 2023 | 617 | 0.520 |
Why?
|
| Interviews as Topic | 10 | 2012 | 428 | 0.520 |
Why?
|
| Attitude | 1 | 2018 | 108 | 0.520 |
Why?
|
| Social Control, Informal | 1 | 2016 | 10 | 0.520 |
Why?
|
| Social Problems | 1 | 2016 | 14 | 0.510 |
Why?
|
| Temperament | 2 | 2015 | 36 | 0.510 |
Why?
|
| Bronchodilator Agents | 6 | 2022 | 26 | 0.490 |
Why?
|
| Medication Adherence | 3 | 2014 | 177 | 0.490 |
Why?
|
| Self Care | 2 | 2016 | 173 | 0.490 |
Why?
|
| Internal-External Control | 3 | 2011 | 60 | 0.470 |
Why?
|
| Anxiety, Separation | 1 | 2015 | 4 | 0.460 |
Why?
|
| Employment | 1 | 2016 | 83 | 0.460 |
Why?
|
| Case Management | 1 | 2014 | 24 | 0.450 |
Why?
|
| Vital Capacity | 7 | 2022 | 44 | 0.450 |
Why?
|
| Smoking | 6 | 2013 | 1019 | 0.440 |
Why?
|
| Obesity | 8 | 2022 | 1131 | 0.430 |
Why?
|
| Caregivers | 7 | 2014 | 195 | 0.430 |
Why?
|
| Interview, Psychological | 9 | 2013 | 63 | 0.420 |
Why?
|
| Patient Education as Topic | 3 | 2016 | 234 | 0.420 |
Why?
|
| Social Adjustment | 3 | 2011 | 30 | 0.420 |
Why?
|
| Respiratory Function Tests | 8 | 2025 | 61 | 0.420 |
Why?
|
| Th2 Cells | 3 | 2025 | 63 | 0.420 |
Why?
|
| Age Factors | 10 | 2020 | 1139 | 0.410 |
Why?
|
| Complementary Therapies | 1 | 2014 | 51 | 0.410 |
Why?
|
| Medicaid | 2 | 2016 | 138 | 0.410 |
Why?
|
| New York | 7 | 2020 | 88 | 0.400 |
Why?
|
| Odds Ratio | 11 | 2019 | 587 | 0.380 |
Why?
|
| Hospitalization | 3 | 2020 | 482 | 0.380 |
Why?
|
| Multivariate Analysis | 11 | 2016 | 638 | 0.370 |
Why?
|
| Pilot Projects | 2 | 2025 | 733 | 0.370 |
Why?
|
| Insurance, Health | 3 | 2021 | 143 | 0.360 |
Why?
|
| Follow-Up Studies | 8 | 2022 | 1051 | 0.360 |
Why?
|
| Lung | 7 | 2022 | 484 | 0.360 |
Why?
|
| Sibling Relations | 1 | 2011 | 1 | 0.350 |
Why?
|
| Infant | 7 | 2021 | 1143 | 0.350 |
Why?
|
| Achievement | 1 | 2011 | 24 | 0.340 |
Why?
|
| Leukocytes | 4 | 2020 | 79 | 0.340 |
Why?
|
| Adaptation, Psychological | 4 | 2016 | 410 | 0.340 |
Why?
|
| Chronic Disease | 4 | 2012 | 541 | 0.330 |
Why?
|
| Sick Role | 1 | 2010 | 9 | 0.330 |
Why?
|
| Antigens, Dermatophagoides | 3 | 2020 | 7 | 0.330 |
Why?
|
| Air Pollution | 3 | 2020 | 87 | 0.330 |
Why?
|
| Family Conflict | 1 | 2010 | 13 | 0.330 |
Why?
|
| Schools | 2 | 2025 | 283 | 0.320 |
Why?
|
| Health Services Needs and Demand | 2 | 2010 | 154 | 0.320 |
Why?
|
| Transients and Migrants | 3 | 2009 | 42 | 0.320 |
Why?
|
| Rhinitis | 2 | 2020 | 17 | 0.320 |
Why?
|
| Sexual Behavior | 4 | 2022 | 634 | 0.320 |
Why?
|
| Hypersensitivity, Immediate | 3 | 2020 | 11 | 0.320 |
Why?
|
| Patient Selection | 1 | 2011 | 192 | 0.310 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 268 | 0.310 |
Why?
|
| Health Status Disparities | 4 | 2012 | 705 | 0.310 |
Why?
|
| Overweight | 2 | 2022 | 248 | 0.310 |
Why?
|
| Forced Expiratory Volume | 5 | 2022 | 75 | 0.300 |
Why?
|
| Cohort Studies | 12 | 2024 | 1729 | 0.300 |
Why?
|
| Cultural Diversity | 5 | 2007 | 187 | 0.290 |
Why?
|
| Drug Therapy | 1 | 2008 | 17 | 0.290 |
Why?
|
| Morbidity | 3 | 2011 | 97 | 0.290 |
Why?
|
| Perception | 1 | 2010 | 209 | 0.290 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 191 | 0.290 |
Why?
|
| Resilience, Psychological | 2 | 2024 | 89 | 0.290 |
Why?
|
| Self Efficacy | 3 | 2025 | 211 | 0.290 |
Why?
|
| Quality of Health Care | 1 | 2009 | 158 | 0.280 |
Why?
|
| Personality Assessment | 6 | 2011 | 44 | 0.280 |
Why?
|
| Epidemiologic Studies | 1 | 2007 | 33 | 0.280 |
Why?
|
| Psychophysiologic Disorders | 2 | 2010 | 8 | 0.270 |
Why?
|
| Treatment Outcome | 9 | 2024 | 1586 | 0.270 |
Why?
|
| Epigenesis, Genetic | 6 | 2023 | 274 | 0.270 |
Why?
|
| Air Pollution, Indoor | 2 | 2020 | 50 | 0.270 |
Why?
|
| Community Mental Health Services | 1 | 2007 | 33 | 0.260 |
Why?
|
| Dominican Republic | 5 | 2014 | 20 | 0.260 |
Why?
|
| Diet | 4 | 2023 | 810 | 0.260 |
Why?
|
| Minority Groups | 7 | 2022 | 663 | 0.260 |
Why?
|
| Research Design | 3 | 2017 | 370 | 0.260 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2018 | 188 | 0.250 |
Why?
|
| Stress, Physiological | 2 | 2020 | 170 | 0.250 |
Why?
|
| Reproducibility of Results | 10 | 2021 | 1058 | 0.250 |
Why?
|
| Community-Based Participatory Research | 1 | 2010 | 336 | 0.250 |
Why?
|
| Genomics | 2 | 2019 | 289 | 0.250 |
Why?
|
| Child Reactive Disorders | 1 | 2005 | 3 | 0.240 |
Why?
|
| Neurotic Disorders | 1 | 2005 | 5 | 0.240 |
Why?
|
| Emigration and Immigration | 5 | 2011 | 85 | 0.240 |
Why?
|
| Chloride Channels | 1 | 2025 | 4 | 0.240 |
Why?
|
| Dust | 3 | 2014 | 55 | 0.230 |
Why?
|
| Vitamin D | 6 | 2022 | 196 | 0.230 |
Why?
|
| Research | 1 | 2006 | 177 | 0.220 |
Why?
|
| Utilization Review | 3 | 2006 | 17 | 0.220 |
Why?
|
| Sleep | 2 | 2023 | 179 | 0.220 |
Why?
|
| Particulate Matter | 1 | 2025 | 80 | 0.220 |
Why?
|
| Child Behavior | 2 | 2019 | 81 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2022 | 727 | 0.210 |
Why?
|
| Age of Onset | 3 | 2011 | 115 | 0.210 |
Why?
|
| Emigrants and Immigrants | 2 | 2021 | 156 | 0.210 |
Why?
|
| Health Services | 2 | 2016 | 62 | 0.210 |
Why?
|
| Genotype | 4 | 2020 | 796 | 0.210 |
Why?
|
| Health Literacy | 3 | 2023 | 120 | 0.210 |
Why?
|
| Interleukin-13 | 1 | 2023 | 20 | 0.210 |
Why?
|
| Tobacco Use Disorder | 1 | 2007 | 249 | 0.210 |
Why?
|
| Fossil Fuels | 1 | 2023 | 2 | 0.210 |
Why?
|
| Disease Progression | 5 | 2023 | 661 | 0.200 |
Why?
|
| Risk-Taking | 2 | 2017 | 456 | 0.200 |
Why?
|
| Sampling Studies | 5 | 2006 | 64 | 0.200 |
Why?
|
| Air Pollutants | 2 | 2025 | 127 | 0.200 |
Why?
|
| Sensation | 3 | 2020 | 36 | 0.200 |
Why?
|
| Pregnancy | 5 | 2021 | 1737 | 0.200 |
Why?
|
| Adolescent Health Services | 1 | 2002 | 29 | 0.190 |
Why?
|
| Crime Victims | 1 | 2022 | 77 | 0.190 |
Why?
|
| Social Behavior | 2 | 2018 | 160 | 0.180 |
Why?
|
| Aged | 14 | 2014 | 7982 | 0.180 |
Why?
|
| Incidence | 6 | 2023 | 1054 | 0.180 |
Why?
|
| Time Factors | 4 | 2014 | 1848 | 0.180 |
Why?
|
| Cannabis | 1 | 2023 | 90 | 0.180 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2020 | 54 | 0.170 |
Why?
|
| Cultural Characteristics | 3 | 2011 | 128 | 0.170 |
Why?
|
| Cultural Competency | 2 | 2014 | 137 | 0.170 |
Why?
|
| Social Values | 2 | 2011 | 31 | 0.170 |
Why?
|
| Vulnerable Populations | 2 | 2024 | 163 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2002 | 471 | 0.170 |
Why?
|
| Administration, Inhalation | 5 | 2024 | 92 | 0.170 |
Why?
|
| Gene Expression Profiling | 5 | 2025 | 683 | 0.170 |
Why?
|
| Vehicle Emissions | 1 | 2020 | 22 | 0.170 |
Why?
|
| CpG Islands | 5 | 2020 | 107 | 0.160 |
Why?
|
| Nerve Net | 1 | 2021 | 96 | 0.160 |
Why?
|
| Puberty | 1 | 2020 | 31 | 0.160 |
Why?
|
| Sulfur Dioxide | 1 | 2019 | 9 | 0.160 |
Why?
|
| Testosterone | 1 | 2021 | 211 | 0.160 |
Why?
|
| Spirometry | 2 | 2010 | 40 | 0.160 |
Why?
|
| Inhalation Exposure | 1 | 2019 | 44 | 0.160 |
Why?
|
| Interferon Regulatory Factors | 1 | 2019 | 18 | 0.160 |
Why?
|
| Gambling | 1 | 2019 | 21 | 0.160 |
Why?
|
| Criminals | 1 | 2019 | 18 | 0.160 |
Why?
|
| Qualitative Research | 2 | 2013 | 526 | 0.160 |
Why?
|
| Cytokines | 3 | 2018 | 661 | 0.150 |
Why?
|
| Unemployment | 3 | 2016 | 27 | 0.150 |
Why?
|
| Sexual Partners | 1 | 2022 | 325 | 0.150 |
Why?
|
| Eosinophils | 3 | 2025 | 22 | 0.150 |
Why?
|
| Homosexuality | 1 | 2019 | 35 | 0.150 |
Why?
|
| Mexico | 4 | 2008 | 286 | 0.150 |
Why?
|
| Adolescent Development | 1 | 2019 | 39 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 84 | 0.150 |
Why?
|
| Estradiol | 1 | 2021 | 269 | 0.150 |
Why?
|
| Universities | 1 | 2023 | 539 | 0.150 |
Why?
|
| Cuba | 3 | 2008 | 31 | 0.150 |
Why?
|
| Interleukin-17 | 2 | 2017 | 53 | 0.150 |
Why?
|
| Quantitative Trait Loci | 2 | 2019 | 88 | 0.150 |
Why?
|
| Heterosexuality | 1 | 2019 | 96 | 0.150 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 2 | 2015 | 4 | 0.140 |
Why?
|
| Affective Symptoms | 2 | 2011 | 60 | 0.140 |
Why?
|
| Human Development | 1 | 2018 | 9 | 0.140 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 1066 | 0.140 |
Why?
|
| Law Enforcement | 1 | 2018 | 14 | 0.140 |
Why?
|
| Interleukin-5 Receptor alpha Subunit | 1 | 2017 | 1 | 0.140 |
Why?
|
| Albuterol | 2 | 2015 | 10 | 0.140 |
Why?
|
| Population | 1 | 2017 | 8 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 577 | 0.140 |
Why?
|
| Genome, Human | 2 | 2017 | 143 | 0.140 |
Why?
|
| Cockroaches | 1 | 2017 | 8 | 0.140 |
Why?
|
| Statistics as Topic | 4 | 2016 | 123 | 0.140 |
Why?
|
| Epithelium | 3 | 2023 | 78 | 0.140 |
Why?
|
| Tropical Climate | 1 | 2017 | 23 | 0.140 |
Why?
|
| Biomedical Research | 2 | 2016 | 467 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2023 | 501 | 0.130 |
Why?
|
| Airway Resistance | 1 | 2017 | 6 | 0.130 |
Why?
|
| Focus Groups | 4 | 2013 | 398 | 0.130 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 63 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 729 | 0.130 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 29 | 0.130 |
Why?
|
| Language | 3 | 2008 | 181 | 0.130 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 200 | 0.130 |
Why?
|
| Drug Resistance | 1 | 2017 | 97 | 0.130 |
Why?
|
| Headache | 3 | 2012 | 21 | 0.130 |
Why?
|
| Attitude to Health | 2 | 2018 | 336 | 0.120 |
Why?
|
| Maternal Exposure | 1 | 2017 | 56 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2014 | 236 | 0.120 |
Why?
|
| Folic Acid Deficiency | 1 | 2016 | 6 | 0.120 |
Why?
|
| Preventive Health Services | 1 | 2016 | 65 | 0.120 |
Why?
|
| Firearms | 1 | 2016 | 16 | 0.120 |
Why?
|
| Phenotype | 4 | 2025 | 774 | 0.120 |
Why?
|
| Inservice Training | 1 | 2016 | 33 | 0.120 |
Why?
|
| Counseling | 1 | 2016 | 134 | 0.120 |
Why?
|
| Weapons | 1 | 2015 | 5 | 0.120 |
Why?
|
| Nurses | 1 | 2016 | 55 | 0.120 |
Why?
|
| Body Mass Index | 5 | 2022 | 916 | 0.120 |
Why?
|
| Psychiatry | 2 | 2007 | 35 | 0.120 |
Why?
|
| World Health Organization | 2 | 2013 | 36 | 0.120 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2015 | 27 | 0.110 |
Why?
|
| Sulfites | 1 | 2015 | 9 | 0.110 |
Why?
|
| Genetic Markers | 3 | 2023 | 146 | 0.110 |
Why?
|
| Needs Assessment | 1 | 2016 | 180 | 0.110 |
Why?
|
| Disability Evaluation | 2 | 2013 | 74 | 0.110 |
Why?
|
| Community Health Services | 1 | 2016 | 207 | 0.110 |
Why?
|
| Androstadienes | 1 | 2014 | 19 | 0.110 |
Why?
|
| Cyclopropanes | 1 | 2014 | 42 | 0.110 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2013 | 5 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2024 | 2485 | 0.110 |
Why?
|
| Models, Biological | 1 | 2017 | 711 | 0.110 |
Why?
|
| Demography | 4 | 2007 | 195 | 0.110 |
Why?
|
| Acetates | 1 | 2014 | 29 | 0.110 |
Why?
|
| Linear Models | 4 | 2015 | 311 | 0.100 |
Why?
|
| Physicians | 1 | 2016 | 180 | 0.100 |
Why?
|
| Abdominal Pain | 2 | 2012 | 25 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2014 | 102 | 0.100 |
Why?
|
| Quinolines | 1 | 2014 | 76 | 0.100 |
Why?
|
| Sulfides | 1 | 2014 | 77 | 0.100 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 233 | 0.100 |
Why?
|
| Object Attachment | 2 | 2011 | 27 | 0.100 |
Why?
|
| Fungi | 1 | 2014 | 103 | 0.100 |
Why?
|
| Friends | 1 | 2013 | 25 | 0.100 |
Why?
|
| Breast Feeding | 1 | 2014 | 123 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 225 | 0.100 |
Why?
|
| Models, Psychological | 2 | 2017 | 141 | 0.100 |
Why?
|
| Risk Assessment | 3 | 2020 | 845 | 0.090 |
Why?
|
| Adiposity | 1 | 2013 | 155 | 0.090 |
Why?
|
| Delivery of Health Care | 2 | 2012 | 309 | 0.090 |
Why?
|
| Population Groups | 2 | 2009 | 59 | 0.090 |
Why?
|
| Premature Birth | 1 | 2013 | 94 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2015 | 461 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 107 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 2 | 2025 | 61 | 0.090 |
Why?
|
| Skin Tests | 3 | 2016 | 13 | 0.090 |
Why?
|
| Boston | 1 | 2010 | 31 | 0.090 |
Why?
|
| Prescriptions | 1 | 2010 | 20 | 0.090 |
Why?
|
| Social Perception | 1 | 2011 | 71 | 0.080 |
Why?
|
| Risk | 1 | 2011 | 289 | 0.080 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 2 | 2008 | 44 | 0.080 |
Why?
|
| Prejudice | 1 | 2011 | 116 | 0.080 |
Why?
|
| Migraine Disorders | 1 | 2010 | 9 | 0.080 |
Why?
|
| Psychopathology | 2 | 2020 | 20 | 0.080 |
Why?
|
| Psychomotor Agitation | 1 | 2010 | 8 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2013 | 429 | 0.080 |
Why?
|
| Continuity of Patient Care | 1 | 2011 | 118 | 0.080 |
Why?
|
| Brain | 1 | 2018 | 1452 | 0.080 |
Why?
|
| Maternal Welfare | 1 | 2009 | 7 | 0.080 |
Why?
|
| Impulsive Behavior | 1 | 2010 | 54 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 76 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2019 | 487 | 0.080 |
Why?
|
| Reference Values | 1 | 2009 | 207 | 0.070 |
Why?
|
| Capacity Building | 1 | 2010 | 99 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2009 | 98 | 0.070 |
Why?
|
| Forecasting | 1 | 2009 | 136 | 0.070 |
Why?
|
| Health Status | 1 | 2012 | 432 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2013 | 574 | 0.070 |
Why?
|
| Program Evaluation | 1 | 2010 | 358 | 0.070 |
Why?
|
| Attention | 1 | 2010 | 165 | 0.070 |
Why?
|
| Crack Cocaine | 2 | 2004 | 8 | 0.070 |
Why?
|
| Endotoxins | 2 | 2020 | 18 | 0.070 |
Why?
|
| Heroin Dependence | 2 | 2004 | 23 | 0.070 |
Why?
|
| Sweden | 2 | 2017 | 17 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 236 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2023 | 722 | 0.070 |
Why?
|
| Mood Disorders | 1 | 2007 | 54 | 0.070 |
Why?
|
| Cocaine-Related Disorders | 2 | 2004 | 99 | 0.070 |
Why?
|
| Ambulatory Care Facilities | 1 | 2007 | 65 | 0.060 |
Why?
|
| Community Health Planning | 1 | 2006 | 38 | 0.060 |
Why?
|
| Dissociative Disorders | 1 | 2006 | 18 | 0.060 |
Why?
|
| Data Collection | 2 | 2008 | 210 | 0.060 |
Why?
|
| Siblings | 1 | 2006 | 22 | 0.060 |
Why?
|
| Animals | 6 | 2024 | 16695 | 0.060 |
Why?
|
| Syndrome | 1 | 2005 | 73 | 0.060 |
Why?
|
| Program Development | 1 | 2006 | 237 | 0.060 |
Why?
|
| Sickness Impact Profile | 1 | 2005 | 25 | 0.060 |
Why?
|
| Mothers | 1 | 2008 | 212 | 0.060 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2025 | 45 | 0.060 |
Why?
|
| Public Health | 2 | 2024 | 405 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2009 | 2803 | 0.060 |
Why?
|
| Hospital Bed Capacity | 1 | 2024 | 5 | 0.060 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2004 | 21 | 0.060 |
Why?
|
| Substance Abuse Detection | 1 | 2004 | 31 | 0.060 |
Why?
|
| Ownership | 1 | 2024 | 12 | 0.050 |
Why?
|
| Cats | 1 | 2024 | 80 | 0.050 |
Why?
|
| Environment | 1 | 2005 | 148 | 0.050 |
Why?
|
| Urban Health | 1 | 2004 | 99 | 0.050 |
Why?
|
| Phobic Disorders | 1 | 2004 | 25 | 0.050 |
Why?
|
| Nose | 1 | 2023 | 12 | 0.050 |
Why?
|
| Dogs | 1 | 2024 | 201 | 0.050 |
Why?
|
| Interpersonal Relations | 1 | 2005 | 216 | 0.050 |
Why?
|
| Hospitals | 1 | 2024 | 115 | 0.050 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2004 | 128 | 0.050 |
Why?
|
| Rural Population | 1 | 2006 | 352 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 358 | 0.050 |
Why?
|
| Registries | 2 | 2017 | 431 | 0.050 |
Why?
|
| Axonemal Dyneins | 1 | 2022 | 6 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 438 | 0.050 |
Why?
|
| Residential Treatment | 1 | 2002 | 7 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2025 | 534 | 0.050 |
Why?
|
| Hospitals, Psychiatric | 1 | 2002 | 16 | 0.050 |
Why?
|
| Self Disclosure | 1 | 2002 | 43 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 2 | 2013 | 157 | 0.040 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2021 | 25 | 0.040 |
Why?
|
| Rest | 1 | 2021 | 33 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2003 | 181 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2021 | 64 | 0.040 |
Why?
|
| Brazil | 1 | 2021 | 83 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2021 | 52 | 0.040 |
Why?
|
| HLA-D Antigens | 1 | 2020 | 1 | 0.040 |
Why?
|
| HLA-DQ Antigens | 1 | 2020 | 6 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2021 | 206 | 0.040 |
Why?
|
| Progesterone | 1 | 2021 | 120 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2021 | 108 | 0.040 |
Why?
|
| Child Day Care Centers | 1 | 2020 | 11 | 0.040 |
Why?
|
| Family Therapy | 1 | 1980 | 22 | 0.040 |
Why?
|
| Twins, Dizygotic | 2 | 2013 | 8 | 0.040 |
Why?
|
| Twins, Monozygotic | 2 | 2013 | 9 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2020 | 203 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2023 | 662 | 0.040 |
Why?
|
| Mexican Americans | 1 | 2022 | 224 | 0.040 |
Why?
|
| Costa Rica | 1 | 2019 | 9 | 0.040 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2019 | 12 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 41 | 0.040 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2019 | 1 | 0.040 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2019 | 2 | 0.040 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2019 | 4 | 0.040 |
Why?
|
| Lectins | 1 | 2019 | 19 | 0.040 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2019 | 9 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2019 | 122 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2019 | 126 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2019 | 181 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 72 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 534 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 557 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2014 | 960 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2017 | 10 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2021 | 548 | 0.030 |
Why?
|
| International Cooperation | 1 | 2017 | 51 | 0.030 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2017 | 2 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 85 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2017 | 26 | 0.030 |
Why?
|
| Proteomics | 1 | 2019 | 363 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 324 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2020 | 426 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2017 | 190 | 0.030 |
Why?
|
| Folic Acid | 1 | 2016 | 49 | 0.030 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2015 | 12 | 0.030 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 19 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 2111 | 0.030 |
Why?
|
| Dairy Products | 1 | 2015 | 34 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2015 | 36 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2015 | 19 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 512 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2017 | 245 | 0.030 |
Why?
|
| Mathematical Concepts | 1 | 2015 | 9 | 0.030 |
Why?
|
| Transportation | 1 | 2014 | 27 | 0.030 |
Why?
|
| Pyroglyphidae | 1 | 2014 | 4 | 0.030 |
Why?
|
| Telephone | 1 | 2014 | 35 | 0.030 |
Why?
|
| Vegetables | 1 | 2015 | 145 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 201 | 0.030 |
Why?
|
| Models, Economic | 1 | 2014 | 30 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2014 | 76 | 0.030 |
Why?
|
| Educational Status | 2 | 2007 | 335 | 0.030 |
Why?
|
| Fruit | 1 | 2015 | 178 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2013 | 34 | 0.030 |
Why?
|
| Translating | 2 | 2004 | 18 | 0.030 |
Why?
|
| Disease Management | 1 | 2014 | 68 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2013 | 90 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2015 | 318 | 0.030 |
Why?
|
| Rwanda | 1 | 2013 | 6 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2015 | 452 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1076 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 176 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 74 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2013 | 134 | 0.020 |
Why?
|
| Proteins | 1 | 2015 | 383 | 0.020 |
Why?
|
| Self Concept | 1 | 2013 | 170 | 0.020 |
Why?
|
| Mice | 2 | 2014 | 6490 | 0.020 |
Why?
|
| Medical Records | 1 | 2012 | 48 | 0.020 |
Why?
|
| Cities | 1 | 2012 | 78 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2012 | 152 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 224 | 0.020 |
Why?
|
| Father-Child Relations | 1 | 2011 | 14 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 508 | 0.020 |
Why?
|
| Emotions | 1 | 2013 | 251 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2011 | 61 | 0.020 |
Why?
|
| Stomach Diseases | 1 | 2010 | 5 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1265 | 0.020 |
Why?
|
| Pregnancy Trimesters | 1 | 2009 | 15 | 0.020 |
Why?
|
| Social Class | 1 | 2012 | 286 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2009 | 79 | 0.020 |
Why?
|
| Language Tests | 1 | 2008 | 22 | 0.020 |
Why?
|
| Child Abuse, Sexual | 1 | 2008 | 22 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2008 | 62 | 0.020 |
Why?
|
| Connecticut | 1 | 2007 | 11 | 0.020 |
Why?
|
| Social Conditions | 1 | 2007 | 13 | 0.020 |
Why?
|
| Psychology | 1 | 2007 | 39 | 0.020 |
Why?
|
| Latin America | 1 | 2006 | 53 | 0.020 |
Why?
|
| Multilingualism | 1 | 2007 | 50 | 0.020 |
Why?
|
| Income | 1 | 2007 | 160 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2006 | 141 | 0.010 |
Why?
|
| Exercise | 1 | 2011 | 674 | 0.010 |
Why?
|
| Domestic Violence | 1 | 2004 | 32 | 0.010 |
Why?
|
| Epidemiologic Research Design | 1 | 2004 | 18 | 0.010 |
Why?
|
| Mass Screening | 1 | 2008 | 531 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2004 | 121 | 0.010 |
Why?
|
| Cognition | 1 | 2007 | 458 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2003 | 95 | 0.010 |
Why?
|
| Decision Making | 1 | 2004 | 242 | 0.010 |
Why?
|
| Family Characteristics | 1 | 1980 | 124 | 0.010 |
Why?
|